文献速递冠心病外科

心包切开联合胺碘酮预防心脏术后房颤的PAPPA研究

Pericardiotomy and Amiodarone for Prophylaxis Against Postoperative Atrial Fibrillation in Cardiac Surgery (PAPPA).
PubMed 文献 · Ann Thorac Surg · 2025-06-21

PAPPA试验在2022-2024年纳入接受孤立冠状动脉旁路移植术的成人患者,给予后心包切开联合低剂量胺碘酮的标准化药物外科预防策略,并与2019-2021年倾向性匹配的历史对照比较。

要点

  • 后心包切开联合低剂量胺碘酮可显著降低孤立CABG术后房颤发生率。
  • 治疗组术后心脏传导阻滞发生率与对照组无统计学差异。
  • 两组30天死亡率和卒中率均无显著差异。

核心结论

  • 在成人心脏手术中,包含后心包切开和低剂量胺碘酮的标准化药物外科预防策略与术后房颤发生率显著降低相关。

研究设计与样本

  • 前瞻性、倾向性匹配、历史对照试验,纳入2022-2024年接受孤立冠状动脉旁路移植术的成人患者204例,与2019-2021年历史对照902例比较,1:1倾向性匹配生成171对平衡配对。

临床怎么用

  • 对于接受孤立冠状动脉旁路移植术的成人患者,可考虑采用后心包切开联合低剂量胺碘酮的标准化预防策略以降低术后房颤发生率。

局限性

  • 研究为历史对照设计,非随机对照试验,可能存在未测量的混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative atrial fibrillation (POAF) is the most common complication after cardiac surgery, occurring in 30%-50% of patients. Although previous studies have suggested a protective benefit from pericardiotomy and prophylactic amiodarone, these practices have not been widely adopted. The Pericardiotomy and Amiodarone for Prophylaxis against Postoperative Atrial Fibrillation (PAPPA) trial was designed to compare the incidence of POAF in cardiac surgery patients who receive a systematic pharmacosurgical prevention strategy vs standard of care. METHODS: In this prospective, propensity-matched, historically controlled trial, adult patients undergoing isolated coronary artery bypass grafting between 2022 and 2024 received a standardized pharmacosurgical intervention including posterior pericardiotomy and low-dose amiodarone. Outcomes in these patients were compared against those in a population of propensity-matched historical controls who underwent isolated coronary artery bypass grafting between 2019 and 2021. The primary endpoint was POAF incidence. RESULTS: A total of 204 patients received the treatment protocol and were compared with 902 historical controls; 1:1 propensity matching generated 171 (84%) balanced pairs. The incidence of POAF was significantly lower in the treatment group compared to matched controls (18.1% vs 31.5%, P = .004). There was no statistically significant difference in the incidence of postoperative heart block between the 2 groups (0.6% vs 1.8%, P = .6228). However, fewer patients in the treatment group were discharged on anticoagulants (8.7% vs 14%, P = .1257). No significant differences were observed in 30-day mortality (0.6% in both groups, P > .99) or stroke rates (0.6% vs 1.2%, P = .562). CONCLUSIONS: In adults undergoing cardiac surgery, standardized pharmacosurgical prophylaxis including posterior pericardiotomy and low-dose amiodarone was associated with significantly lower incidence of POAF.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Makarem A, Paneitz D, Winship T, et al. Pericardiotomy and Amiodarone for Prophylaxis Against Postoperative Atrial Fibrillation in Cardiac Surgery (PAPPA). Ann Thorac Surg. 2025. PMID: 40550318. doi:10.1016/j.athoracsur.2025.05.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。